Viral Conjunctivitis Drugs Market

Global Viral Conjunctivitis Drugs Market Size, Share & Trends Analysis Report, By Drug Class (Artificial Tears, Decongestants, Anti-Histamines, NSAIDS, Anti-Viral Drugs, Steroids, and Antibiotics), By Virus Type (Adenovirus, Enterovirus, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025442 | Category : Pharmaceuticals | Delivery Format: /

The global viral conjunctivitis drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The market is projected to show substantial growth owing to the high number of people suffering from viral conjunctivitis as well as eye-related allergies followed by the easier availability of the necessary treatment across the globe. Although the disease is very common, treatment for it is easily available globally. Generally, viral conjunctivitis is self diagnosable and there is the minimum need of undergoing any diagnostic test for it.

Emerging economies such as India also witnessed a high prevalence of the disease. According to an article published by the journal, Clinical Epidemiology and Global Health, it was discovered that during the year 2019, the prevalence of allergic conjunctivitis was around 12.22% and the number of men suffering from this disease is higher than that of women in India. The epidemiology of the disease is similar in other Asian countries such as China. Hence, due to the high prevalence of the disease, the market is projected to have a steady growth during the forecast period. Furthermore, some key players operating in the market include AbbVie Inc., Takeda Pharmaceutical Co. Ltd., and Bausch Health Co. Inc., among others.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: AbbVie Inc., Takeda Pharmaceutical Co. Ltd., and Bausch Health Co. Inc., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Viral Conjunctivitis Drugs Market by Segment

By Drug Class 

Artificial tears

Decongestants

Anti-histamines

NSAIDS

Anti-Viral drugs

Steroids

Antibiotics

By Virus Type 

Adenovirus

Enterovirus

Others

By Distribution Channel 

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Viral Conjunctivitis Drugs Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World